4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-027984
Chief Development Officer sold 176 shares at $13.11 ($2,307)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Development Officer | 2023-06-12 | Sale | −176 | $13.11 | $2,307 | 90,271 | D: show line 1 in the form |
| Open-market sales · 176 sh · avg $13.11 · $2,307 | |||||||
Loading xslF345X04/ownership.xml…